HRT Financial’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-75,785
| Closed | -$1.5M | – | 2204 |
|
2025
Q1 | $1.5M | Buy |
+75,785
| New | +$1.5M | 0.01% | 798 |
|
2024
Q2 | – | Sell |
-98,656
| Closed | -$651K | – | 1959 |
|
2024
Q1 | $651K | Sell |
98,656
-133,355
| -57% | -$880K | ﹤0.01% | 1058 |
|
2023
Q4 | $1.05M | Sell |
232,011
-17,495
| -7% | -$79K | 0.01% | 894 |
|
2023
Q3 | $893K | Buy |
249,506
+50,872
| +26% | +$182K | 0.01% | 949 |
|
2023
Q2 | $732K | Buy |
+198,634
| New | +$732K | 0.01% | 1051 |
|
2023
Q1 | – | Sell |
-621,348
| Closed | -$2.41M | – | 2237 |
|
2022
Q4 | $2.41M | Buy |
+621,348
| New | +$2.41M | 0.03% | 481 |
|
2021
Q4 | – | Sell |
-118,099
| Closed | -$133K | – | 2799 |
|
2021
Q3 | $133K | Buy |
118,099
+40,158
| +52% | +$45.2K | ﹤0.01% | 2556 |
|
2021
Q2 | $124K | Buy |
77,941
+12,177
| +19% | +$19.4K | ﹤0.01% | 2437 |
|
2021
Q1 | $115K | Buy |
+65,764
| New | +$115K | ﹤0.01% | 2210 |
|
2020
Q3 | – | Sell |
-11,478
| Closed | -$33K | – | 1753 |
|
2020
Q2 | $33K | Buy |
+11,478
| New | +$33K | ﹤0.01% | 1223 |
|